Christopher Nolan's 'Oppenheimer' Creates A Box Office Milestone For An R-Rated Movie
Los Angeles, July 30 - It was another weekend ruled by Barbenheimer, the collective force of "Barbie" and "Oppenheimer" at the global box office. While Margot Robbie-led doll movie crossed $700 million, Nolan's atom bomb flick hit $400 million worldwide through the second weekend.
Based on the life of J. Robert Oppenheimer, an American theoretical physicist who was pivotal in developing the first nuclear weapons as part of the Manhattan Project, "Oppenheimer" is now the first R-Rated movie to gross more than $10 million for seven days in a row — and counting at the domestic (North America) box office, according to Universal Pictures (via Variety).
"Oppenheimer" has grossed $174 million in the first 10 days, and it is yet to drop below the $10 million mark, which is an all-time record. The $174 million includes an excellent $47.2 million second weekend, which is the biggest 2nd weekend total for any drama or an R-Rated movie post the covid-19 pandemic.
Meanwhile, the movie is also performing really well at the Indian box office and has crossed the 100 crores gross mark in just 9 days. It is set to top 100 crores net by the end of the second week to become the first film for Nolan to achieve this milestone in India. It currently stands at approx. 92 crores net through the second weekend (10 days). The total worldwide collection of "Oppenheimer" stands at $400.4 million and it is projected to finish at over $750 million in its lifetime run.
Stay tuned...
Comments
Write Your Comment Here
Max comment length: 100 words; Please don't use bad language otherwise your comment will be removed
Related News
Trending News
Entertainment
Big NewsQuick News
Recent News
Recent Movies
Upcoming Movies
Upcoming Birthdays
Recent Songs
Recent Movies Collection
Sports
Politics
Sports
Internet
India
Education
FeedbackAbout
Contact Us
T&C
Privacy Policy
Cancellation/Refund Policy
Are you a writer/blogger, Work with Us
© Sacnilk Technologies Pvt. Ltd. All Rights Reserved